l General Information |
Product Name | Targocil |
General description | Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis. |
Synonym | 3-(4-chlorophenyl)sulfonyl-N,N-diethyl-7,8-dimethoxytriazolo[1,5-a]quinazolin-5-amine |
Purity | ≥98.5%(HPLC) | CAS Number | 1200443-21-5 |
Formula | C21H22ClN5O4S | Molecular Weight | 475.95 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Light brown solid |
l Biological Information |
Biochem/Physiol Actions | Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA (MIC90s: 2 μg/ mL) for both MRSA and MSSA. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
